» Articles » PMID: 23040451

Second European Evidence-based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 2: Current Management

Citing Articles

Future of Acute Severe Ulcerative Colitis-A Narrative Review.

Pillay L, Selvarajah J, Andrew B, Christensen B, Macrae F, Segal J J Clin Med. 2025; 13(24.

PMID: 39768646 PMC: 11678293. DOI: 10.3390/jcm13247723.


Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023.

Yen H, Wu J, Wang H, Chang T, Chang C, Chang C Intest Res. 2024; 22(3):213-249.

PMID: 39099217 PMC: 11309818. DOI: 10.5217/ir.2023.00050.


Real-life effectiveness and safety of vedolizumab in moderate-to-severe ulcerative colitis: A single-center experience in Northern China.

Yan J, Ding X, Wu J, Liu A, Fang L, Xu Y Medicine (Baltimore). 2024; 103(27):e38759.

PMID: 38968537 PMC: 11224876. DOI: 10.1097/MD.0000000000038759.


Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches.

Lauricella S, Brucchi F, Cavalcoli F, Rausa E, Cassini D, Miccini M J Pers Med. 2024; 14(6).

PMID: 38929801 PMC: 11204779. DOI: 10.3390/jpm14060580.


How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer.

Majumder A, Bano S Biomolecules. 2024; 14(6).

PMID: 38927037 PMC: 11201633. DOI: 10.3390/biom14060633.